Second-line therapy for patients with steroid-refractory aGVHD: systematic review and meta-analysis of randomized controlled trials

ObjectiveSteroids-refractory (SR) acute graft-versus-host disease (aGVHD) is a life-threatening condition in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT), but the optimal second-line therapy still has not been established. We aimed to perform a systematic review...

Descripció completa

Dades bibliogràfiques

Autors principals:	Chengxin Luo, Xiangtao Huang, Ling Wei, Guixian Wu, Yarui Huang, Yaqun Ding, Zhen Huang, Jieping Chen, Xi Li, Yunding Zou, Shuangnian Xu
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2023-06-01
Col·lecció:	Frontiers in Immunology
Matèries:	acute graft-versus-host disease steroids-refractory second-line therapy mesenchymal stroma cells ruxolitinib meta-analysis
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1211171/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!